You are here: Home Media News
ECH newsletter
Sign up for the ECH newsletter and stay informed about homeopathy in Europe


Here you can find news about developments in Europe that are important for homeopathy, news from the European homeopathic community and from the ECH itself

The whole news archive is available below

New insights into high homeopathic dilutions

A team of researchers at the Indian Institute of Technology (IIT), Bombay, have demonstrated the presence of physical entities in extremely high homeopathic dilutions, in the form of nanoparticles of the starting materials and their aggregates.

Homeopathy is controversial because medicines in high potencies such as 30c and 200c involve huge dilution factors which are many orders of magnitude greater than Avogadro’s number, so that theoretically there should be no measurable remnants of the starting materials. No hypothesis which predicts the retention of properties of starting materials has been proposed nor has any physical entity been shown to exist in these high potency medicines.

Using market samples of metal-derived medicines from reputable manufacturers, the researchers have demonstrated for the first time by Transmission Electron Microscopy (TEM), electron diffraction and chemical analysis by Inductively Coupled Plasma-Atomic Emission Spectroscopy (ICP-AES), the presence of physical entities in these extreme dilutions, in the form of nanoparticles of the starting metals and their aggregates.

The confirmed presence of nanoparticles challenges current thinking about the role of dilution in homeopathic medicines. Concrete evidence of the presence of particles as found by this team could help take the research in homeopathy a step forward in understanding these potentised medicines and also help to positively change the perception of the scientific community towards this mode of treatment.

Chikramane PS, Suresh AK, Bellare JR, Kane SG (2010). Extreme homeopathic dilutions retain starting materials: A nanoparticulate perspective. Homeopathy, 99: 231-242 [PubMed]

Share |

CAM back in the Swiss basic health insurance system

The medical practice of homeopathy, Traditional Chinese Medicine, anthroposophic medicine, herbal medicine and neural therapy, which was previously struck off the state insurance list, will be reimbursable from 2012 as part of a six-year trial period.

Back in 2005 the government rejected these complementary (CAM) therapies, arguing they failed to meet the legal requirement of scientific evidence of the three criteria of efficacy, cost-effectiveness and suitability. These three criteria to accept a therapy in the list for reimbursement, are required by the law.

The reversal in policy follows a nationwide vote in 2009 in which two-thirds of Swiss backed expanding the Swiss Federal constitution by an article stipulating that the Federal government and cantons shall ensure that, within the scope of their jurisdiction, complementary medicine is taken into consideration.

As far as the cost-effectiveness of these therapies are concerned, data published in an article in the Swiss Medical Journal* show that even though consultations with doctors who have an additional qualification in homeopathy or other complementary therapies are significantly longer than those in conventional medicine - and leading to a higher patient satisfaction - the total costs per patient per year are not higher and the costs per doctor per year are even 29% lower than in conventional medicine.

The economic benefit of these therapies may have been sufficiently demonstrated, but the health authorities are not yet convinced of the efficacy of the complementary therapies. A federal commission in December 2010 even recommended to strike them permanently from the list because of a 'lack of scientific evidence'. Nevertheless the government has given the medical CAM associations some respite. The associations will have to present conclusive evidence for the efficacy of the complementary therapies by 2017, thus leaving them some time to fill in the gaps for those therapies that so far have not, or only partially, managed to fully meet this requirement.

The evidence is then to go before a recognised international institute for an independent scientific assessment. That institute could be the National Center for Complementary and Alternative Medicine in the USA or the National Institute of Clinical Excellence in the UK.

The government’s decision also includes provisions to boost research and training in the field, which would not be counter-productive, even if there is a negative result for the therapies after the trial period.


* the article in the Swiss Medical Journal - Schweizerische Ärztezeitung  is available here, in German only.

Share |

Nobel laureate Montagnier takes homeopathy seriously

In a truly remarkable interview published in SCIENCE magazine of 24 December, Professor Luc Montagnier, a French virologist who co-discovered HIV and who won the Nobel Prize in 2008, describes his newest work that has significant implications on homeopathy.

Montagnier, who is also founder and president of the World Foundation for AIDS Research and Prevention, makes the following strong statement for homeopathy and homeopathic doses: "I can't say that homeopathy is right in everything. What I can say now is that the high dilutions are right. High dilutions of something are not nothing. They are water structures which mimic the original molecules."

In a study that was published in 2009, Montagnier demonstrated that some bacterial DNA sequences are able to induce electromagnetic waves, even at high aqueous dilutions up to 10^-18. This study was an important contribution to the growing evidence base in fundamental research with direct relevance to homeopathy.

Montagnier will take on the leadership of a new research institute at Jiaotong University in Shanghai and plans to study the phenomenon of electromagnetic waves produced by DNA in water. His research team will study both the theoretical basis and the possible applications in medicine.

In the interview Montagnier says that he cannot pursue this research in France because he does not have much funding there. Because of French retirement laws, he is no longer allowed to work at a public institute. But there is another reason as well. When he applied for funding from other sources, he was turned down. Montagnier argued that there is a kind of fear around this topic in Europe.

In this context he refers to Dr Jacques Benveniste, a French physician/scientist who conducted research on homeopathic doses. Montagnier regards him as a "modern Galileo." "Benveniste was rejected by everybody, because he was too far ahead. He lost everything, his lab, his money. … I think he was mostly right, but the problem was that his results weren't 100% reproducible." "I am told that some people have reproduced Benveniste's results, but they are afraid to publish it because of the intellectual terror from people who don't understand it."

Is Montagnier worried that his colleagues will think he has drifted into pseudoscience? He replies adamantly: "No, because it's not pseudoscience. It's not quackery. These are real phenomena which deserve further study."

The whole interview is available at the website of Science magazine.

Share |

New CAM-quest database launched

The Carstens Foundation in Germany has created a database designed as a search tool for people interested in responsible information on complementary and alternative medicine (CAM).

The aim of CAM-quest is not to rate clinical studies, but rather to demonstrate that a huge body of clinical research in the field of CAM does exist. The database includes research studies in nine therapy categories – acupuncture, anthroposophy, ayurveda, bioenergetics, homeopathy, manual medicine, mind-body medicine, phytomedicine and TCM – and searches can be made by disease, therapy and study design.

The CAM-quest ’quick search’ function provides a fast and easy way to find clinical research which assesses alternative treatments for many common diseases.  However, there is also the option of an ‘expert search’ which allows you to carry out a comprehensive search in CAM clinical research literature, including access to a large number of German homeopathic case reports.

The website presenting the CAM-quest database is currently available in English, French, Dutch and German, but will eventually be translated into all of the European languages.

The database is accessible at

Share |

Homeopathy Research Institute founded

The recently founded Homeopathy Research Institute aims to promote and facilitate high quality research in the field of Homeopathy. The Institute has gathered some of the world's experts in Homeopathy and Complementary and Alternative Medicine research to form their Scientific Advisory Committee.

The Homeopathy Research Institute promotes research in the field of homeopathy by:

  • Facilitating research projects within international academic institutions
  • Providing a peer review process for research proposals submitted to their Scientific Advisory Committee.

They aim to facilitate research which explores different aspects of homeopathy, such as the effectiveness of homeopathy in daily practice, effectiveness in treating key pathologies and the physical properties of homeopathic preparations. They also aim to inform health professionals and the general public about research in homeopathy through the provision of:

  • An online homeopathy research database
  • A free quarterly newsletter covering various homeopathy research topics.

The HRI has established a research database, which comprises randomised controlled trials (RCTs) of homeopathy that have been published in peer-reviewed journals up to 2009. Other such RCTs will be added in due course, and the database will be updated on an ongoing basis to remain a current resource.

The website and the database are accessible at

Share |
Document Actions
Share |